子宮內避孕器市場規模、佔有率、成長分析（按類型、按產品類型、按年齡、按最終用途行業、按地區）- 2025-2032 年行業預測

2023 年全球子宮內避孕器市場規模為 44 億美元，預計將從 2024 年的 46 億美元成長到 2032 年的 66 億美元，預測期間（2025-2032 年）的複合年成長率為 4.6%。

由於人們對計劃生育和生殖健康的認知不斷提高，子宮內避孕器（IUD）市場在過去十年中經歷了顯著成長。子宮內避孕器因其有效性和低維護要求而受到認可，它能提供長期保護，且無需每天護理，因此對忙碌的女性很有吸引力。市場參與企業和衛生組織的意識不斷提高、女性勞動參與率不斷提高以及對非荷爾蒙避孕選擇的需求不斷增加，進一步促進了市場擴張。技術進步和非荷爾蒙子宮內避孕器的引入滿足了女性尋求荷爾蒙避孕替代方法的需求。然而，文化禁忌和對子宮內避孕器安全性的誤解、對其侵入性的認知以及服務不足地區的成本對子宮內避孕器的廣泛採用構成了挑戰。儘管存在這些障礙，子宮內避孕器市場仍在持續成長，尤其是在新興經濟體。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析
• 客戶和購買標準分析

子宮內避孕器市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 荷爾蒙子宮內避孕器
• 銅子宮內避孕器

子宮內避孕器市場規模（依產品類型及複合年成長率）（2025-2032）

• 市場概覽
• 曼月樂
• 斯凱拉
• 帕拉加德
• 以述
• 雷沃塞特
• 其他

子宮內避孕器市場規模（依年齡層別分類）及複合年成長率（2025-2032）

• 市場概覽
• 15-24歲
• 25-34歲
• 35-44歲
• 年齡 44 歲或以上

子宮內避孕器市場規模（依最終用途產業分類）及複合年成長率（2025-2032）

• 市場概覽
• 醫院
• 婦科診所
• 社區醫療中心
• 其他

子宮內避孕器市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Teva Pharmaceutical Industries Ltd.（Jerusalem）
• Bayer（Germany）
• EUROGINE（Spain）
• CooperSurgical Inc.（US）
• Pfizer Inc.（US）
• HLL Lifecare Limited（Thiruvananthapuram）
• OCON Medical Ltd.（Israel）
• Prosan International BV（Netherlands）
• Melbea Innovations（Hungary）
• Allergan, Merck & Co., Inc.（US）
• DKT International（US）
• Medisafe Distribution Inc.（Canada）
• Medicines360（US）
• Pregna International Limited（India）
• Egemen International（Turkey）

結論和建議

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.6 billion in 2024 to USD 6.6 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The Intrauterine Contraceptive Devices (IUDs) market has seen substantial growth over the past decade, driven by heightened awareness of family planning and reproductive health. Recognized for their effectiveness and low maintenance needs, IUDs provide long-lasting protection without daily attention, appealing to busy women. Government initiatives and health organizations have amplified awareness, women's increased participation in the workforce, and a rising demand for hormone-free contraceptive options further bolster market expansion. Technological advancements and the introduction of non-hormonal IUDs cater to women seeking alternatives to hormonal methods. However, cultural taboos and misconceptions regarding IUD safety, alongside the perceived invasiveness of insertion and costs in underserved areas, pose challenges to wider adoption. Despite these hurdles, the IUD market continues to thrive, particularly in emerging economies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Contraceptive Devices Market Segments Analysis

The Global Intrauterine Contraceptive Devices Market is segmented by Type, Product Type, Age Group, End Use and region. Based on Type, the market is segmented into Hormonal Intrauterine Device and Copper Intrauterine Device. Based on Product Type, the market is segmented into Mirena, Skyla, Paragard, Essure, Levosert and Others. Based on Age Group, the market is segmented into 15-24 years, 25-34 years, 35-44 years and Above 44 years. Based on End Use, the market is segmented into Hospitals, Gynecology Clinics, Community Health Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intrauterine Contraceptive Devices Market

The global market for intrauterine contraceptive devices (IUDs) is significantly driven by the increasing adoption of long-acting reversible contraceptives (LARCs). Women are gravitating towards methods that not only provide high effectiveness and low maintenance but also offer long-term pregnancy prevention, with IUDs boasting over 99% effectiveness and lasting 3 to 10 years depending on the type. This makes them a favorable alternative to daily or short-term contraceptive methods. Moreover, the advocacy of healthcare professionals, who often recommend LARCs as a primary contraceptive choice, further boosts IUD usage. Enhanced awareness campaigns highlight the convenience and reliability of these options, increasing their acceptance across diverse demographics and regions.

Restraints in the Global Intrauterine Contraceptive Devices Market

Despite the medical benefits of intrauterine contraceptive devices (IUDs), their adoption is often hindered by cultural and social barriers in many regions globally, including Asia, Africa, and the Middle East. Misconceptions surrounding IUD safety, potential fertility impacts, and procedural discomfort continue to prevail. Additionally, discussions about contraception are frequently stigmatized, leaving women with limited access to effective birth control options like IUDs. Fears about severe side effects and religious objections further inhibit market penetration. To improve awareness and acceptance of IUDs among hesitant groups, targeted educational and community outreach campaigns are essential to dispel myths and promote informed choices.

Market Trends of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices (IUDs) market is experiencing a significant shift towards non-hormonal contraceptive options, driven by growing consumer preference for hormone-free solutions. As awareness of potential side effects associated with hormonal birth control rises, more women are gravitating toward devices like the Copper IUD, which offer long-term efficacy without altering hormonal balance. This trend is particularly pronounced in health-conscious populations seeking non-invasive, reliable alternatives. Consequently, manufacturers are adapting by innovating designs and enhancing comfort in non-hormonal IUDs, positioning these products competitively within the global market landscape and catering to the increasing demand for safer contraceptive choices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Customer & Buying Criteria Analysis

Global Intrauterine Contraceptive Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Hormonal Intrauterine Device
• Copper Intrauterine Device

Global Intrauterine Contraceptive Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Mirena
• Skyla
• Paragard
• Essure
• Levosert
• Others

Global Intrauterine Contraceptive Devices Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 15-24 years
• 25-34 years
• 35-44 years
• Above 44 years

Global Intrauterine Contraceptive Devices Market Size by End Use Industry & CAGR (2025-2032)

• Market Overview
• Hospitals
• Gynecology Clinics
• Community Health Care Centers
• Others

Global Intrauterine Contraceptive Devices Market Size & CAGR (2025-2032)

• North America (Type, Product Type, Age Group, End Use Industry)
  • US
  • Canada
• Europe (Type, Product Type, Age Group, End Use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Age Group, End Use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Age Group, End Use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Age Group, End Use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROGINE (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited (Thiruvananthapuram)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCON Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prosan International BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melbea Innovations (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan, Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360 (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Egemen International (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations